July 9, 2026 · Form 4 insider transaction
Lorrain Daniel S. bought 25 shares of Contineum Therapeutics, Inc. at $1.01 per share, a transaction worth $25.25. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.